Matthew Scalo | SVP, Investor Relations |
Paul Diaz | CEO, President & Director |
Nicole Lambert | COO |
Bryan Riggsbee | EVP, CFO & Treasurer |
Mark Verratti | Chief Commercial Officer. |
Tom Stevens | Cowen and Company |
Jack Meehan | Nephron Research |
Greetings, and welcome to the Myriad Genetics Fourth Quarter 2022 Financial Earnings Conference Call.
During the presentation, all participants will be in a listen-only mode. Afterwards we will conduct a question and answer session. [Operator Instructions].
As a reminder, this conference is being recorded, Tuesday, February 28, 2023.